Q99.2 Billable / specific Fragile X chromosome

ICD-10-CM Q99.2 identifies “Fragile X chromosome” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 17: Congenital malformations, deformations, chromosomal abnormalities, and genetic disorders

Exempt from present-on-admission reporting

Code-level instructions

Inclusion terms1

Fragile X syndrome

Inherited instructions

Chapters 17 · Congenital malformations, deformations, chromosomal abnormalities, and genetic disorders (Q00-QA1)

Excludes 21

inborn errors of metabolism (E70-E88)

Note1

Codes from this chapter are not for use on maternal records

Q90-Q99 · Chromosomal abnormalities, not elsewhere classified (Q90-Q99)

Excludes 21

mitochondrial metabolic disorders (E88.4-)

Official index references

Official index references (2)

Fragile, fragility (1)
Syndrome (1)
History

Code history

Latest recorded change · FY2019

ChangedUnchanged
FY2019

Effective from

  • Inherited rules changed

Fragile X chromosome

Billable diagnosis code

CDC/NCHS · FY2019

All editions (19)

All editionsEffective fromCode history
FY20162015-10-01First observed
FY20172016-10-01No tabular change
FY20182017-10-01No tabular change
FY20192018-10-01Inherited rules changed
FY20202019-10-01No tabular change
FY2020 · April2020-04-01No tabular change
FY20212020-10-01No tabular change
FY2021 · 01-012021-01-01No tabular change
FY20222021-10-01No tabular change
FY2022 · 04-012022-04-01No tabular change
FY20232022-10-01No tabular change
FY2023 · 04-012023-04-01No tabular change
FY20242023-10-01No tabular change
FY2024 · 04-012024-04-01No tabular change
FY20252024-10-01No tabular change
FY2025 · 04-012025-04-01No tabular change
FY20262025-10-01No tabular change
FY2026 · April2026-04-01No tabular change
FY20272026-10-01No tabular change
Historical ICD-9 mappings · 2018

Historical mapping only; not an automatic code substitution.

  • 759.83

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.